Dr John Steer Dr Carlos Echevarria Professor Stephen Bourke Dr Nicholas Lane
| Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients | 2024 |
|
Dr Carlos Echevarria Dr John Steer Dr Arun Prasad Professor Stephen Bourke
| Admission blood eosinophil count, inpatient death and death at 1 year in exacerbating patients with COPD | 2023 |
|
Micaela Mossop Professor Stephen Bourke Dr Fatima Ulhuq Professor Tracy Palmer FRS FRSE FMedSci
| Characterisation of key genotypic and phenotypic traits of clinical cystic fibrosis Staphylococcus aureus isolates | 2023 |
|
Professor Stephen Bourke Dr Simon Doe Dr Carlos Echevarria
| Corrigendum to "Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis" [J Cyst Fibros (2022), 21/2, 323-331, (J Cyst Fibros (2022), 21/2(323-331) (S1569199321014089), (10.1016/j.jcf.2021.09.007)) | 2022 |
|
Dr Hafez Al-momani Professor Christopher Stewart Rhys Jones Amaran Krishnan Dr Andrew Robertson et al. | Exposure to bile and gastric juice can impact the aerodigestive microbiome in people with cystic fibrosis | 2022 |
|
Professor Stephen Bourke
| A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial | 2021 |
|
Dr Iram Haq Dr Mike Althaus Dr Vinciane Saint-Criq Dr Bernard Verdon Dr Jen Townshend et al. | Clinical and molecular characterisation of the R751L-CFTR mutation | 2021 |
|
Dr Nicholas Lane Professor Stephen Bourke
| Effect of portable noninvasive ventilation on thoracoabdominal volumes in recovery from intermittent exercise in patients with COPD | 2021 |
|
David Langton Professor Stephen Bourke Dr Rebecca Darlay Dr Carlos Echevarria
| The influence of HLA genotype on the severity of COVID-19 infection | 2021 |
|
Professor Stephen Bourke Dr Simon Doe Dr Carlos Echevarria
| Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis | 2021 |
|
Professor Christopher Ward Dr John Perry Amaran Krishnan Dr Rhys Jones Professor Jeffrey Pearson et al. | Clonally related viable nontuberculous mycobacteria in gastric juice and sputum in people with cystic fibrosis | 2020 |
|
Dr Nicholas Lane Dr Alice Hartley Professor Stephen Bourke
| Effect of portable non-invasive ventilation on exercise tolerance in COPD: One size does not fit all | 2020 |
|
Dr Carlos Echevarria Dr John Steer Dr Tom Hartley Dr Nicholas Lane Professor Stephen Bourke et al. | Predictors of NIV Treatment in Patients with COPD Exacerbation Complicated by Respiratory Acidaemia | 2020 |
|
Dr Carlos Echevarria Dr John Steer Professor Stephen Bourke
| Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score | 2019 |
|
Dr Nick Lane Dr Tom Hartley Professor Stephen Bourke
| Intermittent Use of Portable NIV Increases Exercise Tolerance in COPD: A Randomised, Cross-Over Trial | 2019 |
|
Mohammad Tariq Dr Giles Holt Dr Clare Lanyon Dr John Perry Professor Stephen Bourke et al. | Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility | 2019 |
|
Professor Stephen Bourke
| Beyond the guidelines for non-invasive ventilation in acute respiratory failure: implications for practice | 2018 |
|
Dr Carlos Echevarria Dr Tom Hartley Dr John Steer Professor John Simpson Emeritus Professor John Gibson et al. | Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation | 2018 |
|
Rhys Jones Amaran Krishnan Dr Malcolm Brodlie Professor Jeffrey Pearson Professor Stephen Bourke et al. | Risk factors for lung disease progression in children with cystic fibrosis | 2018 |
|
Dr Nick Lane Dr John Steer Professor Stephen Bourke
| Specialist emergency care and COPD outcomes | 2018 |
|
Professor Stephen Bourke Emeritus Professor John Gibson
| Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomised clinical trial | 2017 |
|
Dr Hafez Al-momani Rhys Jones Professor Stephen Bourke Dr Simon Doe Dr John Perry et al. | Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis | 2017 |
|
Dr Carlos Echevarria Professor John Simpson Emeritus Professor John Gibson Professor Stephen Bourke
| The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD | 2017 |
|
Professor Stephen Bourke Dr Daya Karat
| DiPALS: Diaphragm Pacing in patients with Amyotrophic Lateral Sclerosis - a randomised controlled trial | 2016 |
|
Dr Carlos Echevarria Andrew Bryant Dr Sally Corbett Dr John Steer Professor Stephen Bourke et al. | Early Supported Discharge/ Hospital At Home For Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: A Review and Meta-Analysis. | 2016 |
|
Professor Stephen Bourke Dr Simon Harris
| Emergence and spread of a humantransmissible multidrug-resistant nontuberculous mycobacterium | 2016 |
|
Dr Carlos Echevarria Dr Colin Muirhead Dr John Steer Professor John Simpson Dr Grant Gibson et al. | Hot decaf: a rct comparing home treatment and inpatient care in copd exacerbations selected by low risk decaf score | 2016 |
|
Professor Stephen Bourke Dr Grant Gibson
| Hot-hmv uk trial secondary outcome analysis: early readmission is reduced by the addition of home mechanical ventilation to home oxygen therapy in copd patients with chronic respiratory failure following a life-threatening exacerbation | 2016 |
|
Dr Hafez Al-momani Professor Christopher Stewart Rhys Jones Amaran Krishnan Dr Andrew Robertson et al. | Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients | 2016 |
|
Lorelle Dismore Dr Carlos Echevarria Professor John Simpson Dr Grant Gibson Professor Stephen Bourke et al. | Positive drivers and potential barriers to implementation of hospital at home selected by low risk decaf score | 2016 |
|
Dr Carlos Echevarria Dr John Steer Dr Chris Stenton Dr Ian Steen Professor John Simpson et al. | Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD | 2016 |
|
Dr John Steer Emeritus Professor John Gibson Professor Stephen Bourke
| Longitudinal change in quality of life following hospitalisation for acute exacerbations of COPD | 2015 |
|
Professor Stephen Bourke Professor Pamela Shaw
| Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial | 2015 |
|
Dr Carlos Echevarria Dr John Steer Dr Chris Stenton Dr Ian Steen Professor John Simpson et al. | The PEARL score predicts 90 day readmission or death following hospitalisation for an exacerbation of COPD | 2015 |
|
Dr Carlos Echevarria Professor Stephen Bourke
| Case-based discussion from North Tyneside General Hospital: somatostatin analogues in yellow nail syndrome associated with recurrent pleural effusions | 2014 |
|
Dr Carlos Echevarria Dr John Steer Professor Stephen Bourke
| Prognostic Value of Platelet Count in Patients Admitted with an Acute Exacerbation of COPD (AECOPD) | 2014 |
|
Dr Carlos Echevarria Dr John Steer Emeritus Professor John Gibson Professor Stephen Bourke
| Red Cell Distribution Width as a Predictor of Hospital Mortality in Acute Exacerbations of COPD (AECOPD) | 2014 |
|
Professor Stephen Bourke
| Respiratory involvement in neuromuscular disease | 2014 |
|
Dr Alistair Gascoigne Professor Stephen Bourke
| Palliative care in the intensive care unit | 2013 |
|
Dr Ali Anwar Dr Sylvia Worthy Professor Stephen Bourke Dr James Lordan Professor Anthony De Soyza et al. | Phenotyping adults with non-cystic fibrosis bronchiectasis: A prospective observational cohort study | 2013 |
|
Professor Stephen Bourke
| Respiratory Care in Neuromuscular Disease | 2013 |
|
Dr John Steer Emeritus Professor John Gibson Professor Stephen Bourke
| Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD | 2012 |
|
Dr Timothy Peel Professor Pamela Shaw Emeritus Professor John Gibson Professor Stephen Bourke
| Non-invasive ventilation in motor neuron disease: an update of current UK practice | 2012 |
|
Dr Carlos Echevarria Professor Stephen Bourke
| Profound bradycardia associated with NIV removal | 2012 |
|
Dr Simon Baudouin Professor Stephen Bourke Dr Daya Karat Tom Williams
| Protocol for diaphragm pacing in patients with respiratory muscle weakness due to motor neurone disease (DiPALS): a randomised controlled trial | 2012 |
|
Professor Stephen Bourke Dr Timothy Peel Emeritus Professor John Gibson Professor Pamela Shaw
| The changing landscape of non-invasive ventilation in amyotrophic lateral sclerosis | 2012 |
|
Emeritus Professor John Gibson Professor Stephen Bourke
| The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease | 2012 |
|
Professor Stephen Bourke Emeritus Professor John Gibson
| Amyotrophic lateral sclerosis | 2010 |
|
Dr Ali Anwar Professor Stephen Bourke Dr Peter Middleton Professor Christopher Ward Dr Robert Rutherford et al. | Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis colonised with Pseudomonas aeruginosa | 2010 |
|
Dr Timothy Peel Professor Pamela Shaw Professor Stephen Bourke
| Non-invasive ventilation in motor neurone disease: an update of current UK practice [abstract] | 2010 |
|
Dr John Steer Emeritus Professor John Gibson Professor Stephen Bourke
| Predicting outcomes following hospitalization for acute exacerbations of COPD | 2010 |
|
Dr Ali Anwar Professor Stephen Bourke Dr Peter Middleton Professor Christopher Ward Dr Robert Rutherford et al. | Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis | 2008 |
|
Professor Stephen Bourke Dr Timothy Williams Dr Robert Bullock Professor Pamela Shaw Emeritus Professor John Gibson et al. | Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: A randomised controlled trial | 2006 |
|
Professor Stephen Bourke Dr Robert Bullock Professor Pamela Shaw Emeritus Professor John Gibson
| Non-invasive ventilation in amyotrophic lateral sclerosis | 2006 |
|
Professor Stephen Bourke Therese Small Dr Timothy Williams Emeritus Professor John Gibson
| Respiratory function and survival in motor neurone disease | 2006 |
|
Professor Stephen Bourke Dr Robert Bullock Professor Pamela Shaw
| A randomised controlled trial of non-invasive ventilation (NIV) in motor neurone disease (MND) | 2005 |
|
Professor Christopher Baldwin Professor Adrian Allen Professor Stephen Bourke Emerita Professor Jane Calvert
| Mucin oligosaccharides and pigeon fanciers' lung | 2005 |
|
Dr Naweed Sattar Professor Stephen Bourke
| Serum lipids in pigeon fanciers' hypersensitivity pneumonitis: A place for statins? | 2005 |
|
Professor Christopher Baldwin Professor Adrian Allen Professor Stephen Bourke Emerita Professor Jane Calvert
| Mucin oligosaccharides and pigeon fanciers' lung | 2004 |
|
Professor Stephen Bourke Emeritus Professor John Gibson
| Non-invasive ventilation in ALS: Current practice and future role | 2004 |
|
Professor Stephen Bourke Professor Pamela Shaw Dr Robert Bullock Emeritus Professor John Gibson
| Randomised controlled trial of now invasive ventilation in motor neurone disease | 2004 |
|
Professor Stephen Bourke Emerita Professor Elaine McColl Professor Pamela Shaw Emeritus Professor John Gibson
| Validation of quality of life instruments in ALS | 2004 |
|
Professor Stephen Bourke Emeritus Professor John Gibson
| Erdheim-Chester disease: Pulmonary infiltration responding to cyclophosphamide and prednisolone | 2003 |
|
Professor Stephen Bourke Dr Robert Bullock Professor Pamela Shaw Emeritus Professor John Gibson
| Noninvasive ventilation in ALS: Indications and effect on quality of life | 2003 |
|
Professor Stephen Bourke Professor Pamela Shaw Dr Robert Bullock
| Criteria for initiating non-invasive ventilation in motor neuron disease | 2002 |
|
Professor Stephen Bourke Professor Pamela Shaw Dr Timothy Williams
| Non-invasive ventilation in motor neuron disease: Current UK practice | 2002 |
|
Professor Stephen Bourke Dr Robert Bullock Emeritus Professor John Gibson Professor Pamela Shaw
| Non-invasive ventilation in motor neuron disease: Current UK practice | 2002 |
|
Professor Stephen Bourke Emeritus Professor John Gibson
| Predictors of benefit from, and compliance with, non-invasive ventilation in motor neurone disease | 2002 |
|
Professor Stephen Bourke Professor Pamela Shaw Dr Robert Bullock
| Responsiveness of quality of life instruments and domains to non-invasive ventilation in motor neuron disease | 2002 |
|
Professor Stephen Bourke Emeritus Professor John Gibson
| Sleep and breathing in neuromuscular disease | 2002 |
|
Professor Stephen Bourke Professor Pamela Shaw
| Daytime predictors of nocturnal desaturation in motor neurone disease | 2001 |
|
Professor Stephen Bourke Professor Pamela Shaw Emeritus Professor John Gibson
| Respiratory function vs sleep-disordered breathing as predictors of QOL in ALS | 2001 |
|
Professor Stephen Bourke
| Review of cryptogenic fibrosing alveolitis, including current treatment guidelines | 2000 |
|